{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T22:10:12Z","timestamp":1728943812783},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,14]]},"DOI":"10.7759\/cureus.71471","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T21:28:36Z","timestamp":1728941316000},"source":"Crossref","is-referenced-by-count":0,"title":["Hypercalcemia-Associated Hodgkin's Lymphoma Presenting as Normal Pressure Hydrocephalus: A Case Report"],"prefix":"10.7759","author":[{"given":"Sean","family":"Lief","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Z","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samer","family":"Beauti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel B","family":"Lichtenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srihita","family":"Patibandla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azouba","family":"Gulraiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul R","family":"Tirumalareddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mashaal","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27041310","article-title":"Targeted drug delivery for the treatment of blood cancers","volume":"27","author":"Jiang Y","year":"2022","unstructured":"Jiang Y, Lin W, Zhu L. Targeted drug delivery for the treatment of blood cancers. Molecules. 2022, 27:10.3390\/molecules27041310","journal-title":"Molecules"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21438","article-title":"Hodgkin lymphoma: a review and update on recent progress","volume":"68","author":"Shanbhag S","year":"2018","unstructured":"Shanbhag S, Ambinder RF. Hodgkin lymphoma: a review and update on recent progress. CA Cancer J Clin. 2018, 68:116-32. 10.3322\/caac.21438","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2012.07.002","article-title":"Hodgkin lymphoma","volume":"85","author":"Gobbi PG","year":"2013","unstructured":"Gobbi PG, Ferreri AJ, Ponzoni M, Levis A. Hodgkin lymphoma. Crit Rev Oncol Hematol. 2013, 85:216-37. 10.1016\/j.critrevonc.2012.07.002","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26717","article-title":"Hodgkin lymphoma: 2023 update on diagnosis, risk-stratification, and management","volume":"97","author":"Ansell SM","year":"2022","unstructured":"Ansell SM. Hodgkin lymphoma: 2023 update on diagnosis, risk-stratification, and management. Am J Hematol. 2022, 97:1478-88. 10.1002\/ajh.26717","journal-title":"Am J Hematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2217\/cns-2017-0033","article-title":"Management of extranodal lymphoma of the spine: a study of 30 patients","volume":"7","author":"Hashi S","year":"2018","unstructured":"Hashi S, Goodwin CR, Ahmed AK, Sciubba DM. Management of extranodal lymphoma of the spine: a study of 30 patients. CNS Oncol. 2018, 7:CNS11. 10.2217\/cns-2017-0033","journal-title":"CNS Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000000305","article-title":"Diagnosis and treatment of idiopathic normal pressure hydrocephalus","volume":"22","author":"Williams MA","year":"2016","unstructured":"Williams MA, Malm J. Diagnosis and treatment of idiopathic normal pressure hydrocephalus. Continuum (Minneap Minn). 2016, 22:579-99. 10.1212\/CON.0000000000000305","journal-title":"Continuum (Minneap Minn)"},{"key":"ref7","article-title":"Nodular lymphocyte predominant Hodgkin\u2019s lymphoma presenting as severe hypercalcaemia: a case report","volume":"7","author":"Burney IA","year":"2007","unstructured":"Burney IA, Nirmala V, Al-Moundhri MS, Woodhouse NJ. Nodular lymphocyte predominant Hodgkin\u2019s lymphoma presenting as severe hypercalcaemia: a case report. Sultan Qaboos Univ Med J. 2007, 7:247-51.","journal-title":"Sultan Qaboos Univ Med J"},{"key":"ref8","article-title":"Diagnosis of urinary incontinence","volume":"87","author":"Khandelwal C","year":"2013","unstructured":"Khandelwal C, Kistler C. Diagnosis of urinary incontinence. Am Fam Physician. 2013, 87:543-50.","journal-title":"Am Fam Physician"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1039490","article-title":"Cancer-related hypercalcemia and potential treatments","volume":"14","author":"Almuradova E","year":"2023","unstructured":"Almuradova E, Cicin I. Cancer-related hypercalcemia and potential treatments. Front Endocrinol (Lausanne). 2023, 14:1039490. 10.3389\/fendo.2023.1039490","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21489","article-title":"Hypercalcemia and cancer: differential diagnosis and treatment","volume":"68","author":"Zagzag J","year":"2018","unstructured":"Zagzag J, Hu MI, Fisher SB, Perrier ND. Hypercalcemia and cancer: differential diagnosis and treatment. CA Cancer J Clin. 2018, 68:377-86. 10.3322\/caac.21489","journal-title":"CA Cancer J Clin"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson BD","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014, 32:3059-68. 10.1200\/JCO.2013.54.8800","journal-title":"J Clin Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/nop\/npaa058","article-title":"Metastatic spine oncology: symptom-directed management","volume":"7","author":"Ruppert LM","year":"2020","unstructured":"Ruppert LM, Reilly J. Metastatic spine oncology: symptom-directed management. Neurooncol Pract. 2020, 7:i54-61. 10.1093\/nop\/npaa058","journal-title":"Neurooncol Pract"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/281966-hypercalcemia-associated-hodgkins-lymphoma-presenting-as-normal-pressure-hydrocephalus-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T21:28:37Z","timestamp":1728941317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/281966-hypercalcemia-associated-hodgkins-lymphoma-presenting-as-normal-pressure-hydrocephalus-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,14]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.71471","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,14]]}}}